September 2023 Legislative & Regulatory Briefing: Access to PDTs Act of 2023 Discussed in a House Energy & Committee Hearing; AMCP Comments on Coverage with Evidence Development Proposed Guidance; Adam Colborn Discusses AMCP’s Legislative & Regulatory Priorities for 2023; Now Available: AMCP’s Inflation Reduction Act Resource Center; 2023 Call for AMCP Committee Applications Now Open.
On August 21, 2023, CMS Issued the Maximum Monthly Cap on Cost-Sharing Payments Under Prescription Drug Plans: Draft Part One Guidance on Select Topics, Implementation of Section 1860D-2 of the Social Security Act for 2025. The purpose of this document is to provide interested parties with draft part one guidance on a select set of topics for the Maximum Monthly Cap on Cost-Sharing Payments Program.
The Disabilities Health Equity Action Brief provides an overview of the barriers to medication use and health outcomes due to disabilities, and how managed care can identify the gaps in care and develop interventions to address these health inequities due to disabilities for their health plan members.
HIV, or Human Immunodeficiency Virus, is a retrovirus that attacks the immune system, leading to a progressive weakening of the body's natural defenses against infections and diseases.
Host Fred Goldstein discusses current biologic options and the impact to the Immunology Market landscape with Michael Rothrock MHA, MBA, and Chronis H. Manolis, RPh.